AC Immune SA (ACIU)
3.21
-0.20
(-5.87%)
USD |
NASDAQ |
May 17, 16:00
3.21
0.00 (0.00%)
After-Hours: 20:00
AC Immune Cash and Short Term Investments (Quarterly): 116.17M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 116.17M |
| December 31, 2023 | 122.68M |
| September 30, 2023 | 87.36M |
| June 30, 2023 | 103.43M |
| March 31, 2023 | 115.42M |
| December 31, 2022 | 132.22M |
| September 30, 2022 | 144.08M |
| June 30, 2022 | 161.52M |
| March 31, 2022 | 188.29M |
| December 31, 2021 | 216.84M |
| September 30, 2021 | 201.81M |
| June 30, 2021 | 216.22M |
| March 31, 2021 | 229.40M |
| December 31, 2020 | 258.55M |
| September 30, 2020 | 268.13M |
| June 30, 2020 | 275.96M |
| March 31, 2020 | 289.42M |
| Date | Value |
|---|---|
| December 31, 2019 | 297.84M |
| September 30, 2019 | 305.12M |
| June 30, 2019 | 292.51M |
| March 31, 2019 | 303.44M |
| December 31, 2018 | 189.39M |
| September 30, 2018 | 202.91M |
| June 30, 2018 | 102.90M |
| March 31, 2018 | 115.01M |
| December 31, 2017 | 127.69M |
| September 30, 2017 | 120.74M |
| June 30, 2017 | 129.95M |
| March 31, 2017 | 138.01M |
| December 31, 2016 | 149.58M |
| September 30, 2016 | 163.09M |
| June 30, 2016 | 84.08M |
| March 31, 2016 | 70.32M |
| December 31, 2015 | 77.42M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
87.36M
Minimum
Sep 2023
305.12M
Maximum
Sep 2019
201.15M
Average
209.02M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| CRISPR Therapeutics AG | 2.108B |
| Addex Therapeutics Ltd | 4.603M |
| NLS Pharmaceutics Ltd | 0.8977M |
| Molecular Partners AG | 222.50M |
| MoonLake Immunotherapeutics | 547.05M |